相似文献
1
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
Drug Deliv. 2017 Dec;24(sup1):16-21. doi: 10.1080/10717544.2017.1384518.
2
[Recent development of natural and reconstituted lipoprotein based nano drug delivery vehicles].
Yao Xue Xue Bao. 2014 Jan;49(1):23-9.
3
Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Cancer Chemother Pharmacol. 2018 Sep;82(3):371-382. doi: 10.1007/s00280-018-3626-4. Epub 2018 Jun 18.
4
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.
Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):251-76. doi: 10.1016/s0169-409x(01)00109-0.
5
Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.
J Control Release. 2002 Apr 23;80(1-3):29-44. doi: 10.1016/s0168-3659(01)00536-3.
6
Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.
Expert Opin Drug Deliv. 2007 Nov;4(6):665-75. doi: 10.1517/17425247.4.6.665.
7
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.
Drug Deliv. 2021 Dec;28(1):408-421. doi: 10.1080/10717544.2021.1886199.
8
Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.
Curr Pharm Des. 2016;22(22):3466-85. doi: 10.2174/1381612822666160209152555.
9
A high-density lipoprotein-mediated drug delivery system.
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):132-147. doi: 10.1016/j.addr.2016.04.030. Epub 2016 May 18.
10
Lipoprotein-inspired nanoparticles for cancer theranostics.
Acc Chem Res. 2011 Oct 18;44(10):1105-13. doi: 10.1021/ar200017e. Epub 2011 May 10.
引用本文的文献
1
Nano Delivery System for Atherosclerosis.
J Funct Biomater. 2024 Dec 24;16(1):2. doi: 10.3390/jfb16010002.
2
Advances on Delivery System of Active Ingredients of Dried Toad Skin and Toad Venom.
Int J Nanomedicine. 2024 Jul 18;19:7273-7305. doi: 10.2147/IJN.S469742. eCollection 2024.
3
Biomembrane-Derived Nanoparticles in Alzheimer's Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles.
Int J Nanomedicine. 2023 Dec 7;18:7441-7468. doi: 10.2147/IJN.S436774. eCollection 2023.
4
Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers.
Drug Deliv. 2022 Dec;29(1):2206-2216. doi: 10.1080/10717544.2022.2096713.
5
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.
Pharmaceutics. 2021 Jun 7;13(6):840. doi: 10.3390/pharmaceutics13060840.
6
Assessing the potential use of chitosan scaffolds for the sustained localized delivery of vitamin D.
Saudi J Biol Sci. 2021 Apr;28(4):2210-2215. doi: 10.1016/j.sjbs.2021.01.008. Epub 2021 Jan 20.
7
Lipoprotein-based drug delivery.
Adv Drug Deliv Rev. 2020;159:377-390. doi: 10.1016/j.addr.2020.08.003. Epub 2020 Aug 11.
8
Establishment of a hTfR mAb-functionalized HPPS theranostic nanoplatform.
Nanotheranostics. 2020 Mar 26;4(3):119-128. doi: 10.7150/ntno.41741. eCollection 2020.
9
Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells.
Heliyon. 2019 Apr 28;5(4):e01573. doi: 10.1016/j.heliyon.2019.e01573. eCollection 2019 Apr.
本文引用的文献
1
Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
Int J Nanomedicine. 2016 Nov 22;11:6229-6238. doi: 10.2147/IJN.S112835. eCollection 2016.
2
Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
Mol Pharm. 2016 Nov 7;13(11):3976-3987. doi: 10.1021/acs.molpharmaceut.6b00781. Epub 2016 Oct 12.
3
Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity.
Oncotarget. 2016 Aug 9;7(32):51535-51552. doi: 10.18632/oncotarget.10493.
4
Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.
Nanomedicine. 2016 Oct;12(7):2161-2179. doi: 10.1016/j.nano.2016.05.009. Epub 2016 May 26.
5
Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent.
J Photochem Photobiol B. 2016 Feb;155:60-5. doi: 10.1016/j.jphotobiol.2015.12.007. Epub 2015 Dec 18.
6
Synthetic High-Density Lipoprotein-Like Nanocarrier Improved Cellular Transport of Lysosomal Cholesterol in Human Sterol Carrier Protein-Deficient Fibroblasts.
J Med Food. 2016 Jan;19(1):62-7. doi: 10.1089/jmf.2015.3578. Epub 2015 Dec 18.
7
Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas.
Biochem Cell Biol. 2015 Aug;93(4):343-50. doi: 10.1139/bcb-2015-0009. Epub 2015 Apr 20.
8
Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.
Small. 2014 Aug 13;10(15):3072-82. doi: 10.1002/smll.201303842. Epub 2014 Apr 6.
9
Ligand-coupled lipoprotein for ovarian cancer-specific drug delivery.
Methods Mol Biol. 2013;1049:467-80. doi: 10.1007/978-1-62703-547-7_35.
10
Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.
Bioimpacts. 2013;3(2):53-65. doi: 10.5681/bi.2013.007. Epub 2013 Jan 14.
Zotero 插件